首页 › 基金 › ORBIMED ADVISORS LLC › ARQT

ORBIMED ADVISORS LLC 对 ARQT 的持仓历史

ARCUTIS BIOTHERAPEUTICS INC · 医疗保健

ORBIMED ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 ARQT(ARCUTIS BIOTHERAPEUTICS INC)2,042,000 股,市值约 US$53.5M,约占其申报组合的 1.08%,在其申报持仓中市值排名第 28 位。 ORBIMED ADVISORS LLC 最近 12 个申报季度中有 2 个季度披露了 ARQT 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q2 2026)2.04M 股
申报持仓市值$53.54M
组合权重1.08%
首次申报Q3 2023
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

ORBIMED ADVISORS LLC 对 ARQT 的持仓演变

ORBIMED ADVISORS LLC 于 Q3 2023 首次披露 ARQT 持仓:1,914,479 股(约 US$10.2M)。 该持仓在 Q2 2026 达到峰值 2,042,000 股,市值约 US$53.5M。 在 2 次申报中,ORBIMED ADVISORS LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 2,042,000 股、市值约 US$53.5M。

逐季持仓明细

季度股数金额变化
Q3 2023 1.91M $10.17M 新进
Q2 2026 2.04M $53.54M 新进

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ARQT 与 13F 数据

ARQT(ARCUTIS BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 ARQT,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$326.1M), Frazier Life Sciences Management, L.P. (US$258.9M), Rubric Capital Management LP (US$216.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ARQT 的基金

查看 ARQT 的全部基金持有人 →

常见问题

How long has ORBIMED ADVISORS LLC held ARQT?

ORBIMED ADVISORS LLC has disclosed ARQT holdings in 2 of the last 12 reported quarters, going back to Q3 2023.

What is ORBIMED ADVISORS LLC's current position in ARQT?

As of Q2 2026, ORBIMED ADVISORS LLC holds 2.04M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), valued at $53.54M, representing 1.08% of its reported portfolio and ranking #28.

Has ORBIMED ADVISORS LLC been buying or selling ARQT?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC newly opened its position in ARQT. The position peaked in Q2 2026 at 2.04M shares.

Which other funds hold ARQT?

Other major institutional holders of ARQT include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.